[1] Kwan A, Abraham R, Currier R, et al.Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States[J].JAMA,2014,312:729-738. [2] Fuchs S, Rensing-Ehl A, Erlacher M, et al.Patients with T /low NK IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency[J].J Pediatr Hematol Oncol, 2014,44(10):3129-3140. [3] Tan W, Yu S, Lei J, et al.A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T NK B+)[J].Immunogenetics,2015,67(11-12):629-639. [4] Markiewicz S, Subtil A, Dautry-Varsat A, et al.Detection of three nonsense mutations and one missense mutation in the interleukin-2 receptor gamma chain gene in SCIDX1 that differently affect the mRNA processing[J].Genomics,1994,21(1):291-293. [5] Pepper AE, Buckley RH, Small TN, et al.Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency[J].Am J Hum Genet, 1995,57(3):564-571. [6] Noguchi M,Yi H,Rosenblatt HM,et a1.Interleukin-2 receptor g chain mutation resuhs in X-linked severe combined immunodeficiency in humans[J].Cell,1993,73(1):147-157. [7] Klatzmann D, Abbas AK.The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases[J].Nat Rev Immunol, 2015,15(5):283-294. [8] Mou W, He J, Chen X, et al.A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiencywith an atypical phenotype[J].Immunogenetics,2017,69(1):29-38. [9] Nourizadeh M, Shakerian L, Borte S, et al.Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran[J].Scand J Immunol, 2018,26:e12699. [10] 孔祥东,刘宁,徐学聚,等.IL2RG基因新突变致X-连锁重症联合免疫缺陷病二例及产前诊断研究[J].中华医学杂志,2014,94(16):1227-1231. [11] 刘钋宁,李虹,李强.白细胞介素-2受体共同γ链基因突变致X-连锁重症联合免疫缺陷病的临床分析[J].中华妇幼临床医学杂志:电子版,2014,10(3):70-74. [12] 吴庆华,史惠蓉,刘宁,等.X-连锁严重联合免疫缺陷病一家系突变分析及产前诊断研究[J].中华儿科杂志,2012,50(12):851-854. [13] 吴海涛,沈晓婷,江青剑,等.X连锁严重联合免疫缺陷病的植入前遗传学诊断[J].中山大学学报:医学科学版,2017,38(6):955-960. |